Cover image

Cover image: Diagnostic work-up and treatment regimes in an alemtuzumab-treated patient with RRMS developing idiopathic multicentric Castleman's disease (Panels I and J shown). “(I) H&E staining of bone marrow puncture displaying megakaryocytosis. (J) Mediastinal lymph node biopsy consistent with iMCD plasma-cell type. (J) H&E staining: regressive germinal centers (blue arrows), with small vessels reaching into germinal centers (“lollipop vessels”, black arrows).”. See page e638